ReviewFrontiers in immunology2026

PD-1 blockade combined with anlotinib and bicalutamide for metastatic primary cutaneous apocrine carcinoma: a case report and literature review.

Yuqi Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.